BIOVERATIV INC. Share-based Payment Arrangement, Expense
BIOVERATIV INC. reported Share-based Payment Arrangement, Expense of $32.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2018-02-14
- BIOVERATIV INC. share-based payment arrangement, expense for the quarter ending 2017-12-31 was $5.00M, a 25.00% increase year-over-year.
- BIOVERATIV INC. share-based payment arrangement, expense for the quarter ending 2017-09-30 was $9.20M, a 84.00% increase year-over-year.
- BIOVERATIV INC. share-based payment arrangement, expense for the quarter ending 2017-06-30 was $11.80M, a 210.53% increase year-over-year.
- BIOVERATIV INC. share-based payment arrangement, expense for the quarter ending 2017-03-31 was $6.00M, a 140.00% increase year-over-year.
- BIOVERATIV INC. share-based payment arrangement, expense for fiscal 2017 was $32.00M, a 109.15% increase from fiscal 2016.
- BIOVERATIV INC. share-based payment arrangement, expense for fiscal 2016 was $15.30M, a 15.91% increase from fiscal 2015.
- BIOVERATIV INC. share-based payment arrangement, expense for fiscal 2015 was $13.20M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2017-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $14.20M derived: sum of 2 quarters · filed 2018-02-14 | $26.00M derived: sum of 3 quarters · filed 2018-02-14 | $32.00M 10-K · filed 2018-02-14 |
| 2017-09-30 | $9.20M 10-Q · filed 2017-10-27 | $21.00M derived: sum of 2 quarters · filed 2017-10-27 | $27.00M 10-Q · filed 2017-10-27 | $31.00M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-06-30 | $11.80M 10-Q · filed 2017-08-03 | $17.80M 10-Q · filed 2017-08-03 | $21.80M derived: sum of 3 quarters · filed 2018-02-14 | $26.80M derived: sum of 4 quarters · filed 2018-02-14 |
| 2017-03-31 | $6.00M 10-Q · filed 2017-05-12 | $10.00M derived: sum of 2 quarters · filed 2018-02-14 | $15.00M derived: sum of 3 quarters · filed 2018-02-14 | $18.80M derived: sum of 4 quarters · filed 2018-02-14 |
| 2016-12-31 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-14 | $9.00M derived: sum of 2 quarters · filed 2018-02-14 | $12.80M derived: sum of 3 quarters · filed 2018-02-14 | $15.30M 10-K · filed 2018-02-14 |
| 2016-09-30 | $5.00M 10-Q · filed 2017-10-27 | $8.80M derived: sum of 2 quarters · filed 2017-10-27 | $11.30M 10-Q · filed 2017-10-27 | |
| 2016-06-30 | $3.80M 10-Q · filed 2017-08-03 | $6.30M 10-Q · filed 2017-08-03 | ||
| 2016-03-31 | $2.50M 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | $13.20M 10-K · filed 2018-02-14 |